Notice of extraordinary shareholders meeting in Dignitana AB (publ)

The shareholders of Dignitana AB (publ), 556730-5346, ("the Company") are hereby invited to attend the Extraordinary Shareholders Meeting on Friday 16 March 2018 at 13.00 in the Company's premises, Traktorgränden 3, in Lund.

Registration, etc.
Shareholders who wish to participate in the Shareholders meeting shall:

• Be included in the share register kept by Euroclear Sweden AB on Saturday 10 March 2018

• Notify by email to or by telephone 046-163090 by no later than Monday 12 March 2018

The notification must state the name of the shareholder, person or organization number, shareholding, address, telephone number, details of possible assistants (no more than 2), as well as, where applicable, deputy or representative. The notification should, where appropriate, be accompanied by proxies, registration certificates and other documents of authority.

Nominee-registered shares (Sw. Förvaltarregistrerade aktier)
Shareholders with nominee shares must, to be entitled to attend the Shareholders meeting, register their shares in their own name in the share register kept by Euroclear Sweden AB. Such registration must be done before Friday 9 March 2018. This means that shareholders must notify their trustee ahead of this day.

Proxy, etc.
Shareholders represented by proxy shall issue a dated proxy for the representative. If the power of attorney is issued by a legal person, a certified copy of the registration certificate or equivalent of the legal person must be attached. Validity of the power of attorney may be entered for a maximum period of five years from the date of issue. The original authorization and any registration certificate should be sent by letter to the Company before the meeting.

Agenda draft:
0. Opening of the meeting
1. Election of Chairman of the Meeting.
2. Establishment and approval of voting list.
3. Approval of agenda.
4. Election of one or two persons to verify the minutes.
5. Examination of whether the meeting has been duly convened.
6. Election of Board.
7. Determination of Board fees.
8. The meeting ends.


Determination of board fees and election of board (items 6 and 7)

The Nomination Committee proposes, that the Board shall consist of four Board members without deputy board member, and that William Cronin will be re-elected, and
Thomas Kelly, Ingrid Atteryd Heiman and Mikael Wahlgren will be elected as regular Board members, as well as the election of Thomas Kelly as Chairman of the Board.

The Nomination Committee in Dignitana has announced that it proposes that the Board fee be paid at 100 000 SEK to the Swedish Board members. The Americans who are proposed to be elected to board members will, if they are elected, also be elected as members of the Dignitana Inc. Board, and are hereby proposed to receive an ordinary payment of 12 000 USD per person. Therefore, the Nomination Committee proposes that no Board fees will be paid to the American Board members for the assignment in Dignitana AB, and instead compensation for the assignment in Dignitana, Inc. will be paid for as stated above.

Provision of documents
Proxy form can be obtained at the Company's website, Alternatively, it is sent free of charge to shareholders who request it (see contact details above) and provide their postal address or email address. All other documents are also sent free of cost to those shareholders who request it and who provide their postal address. The documents will also be available at the meeting.


Lund February 2018

Dignitana AB (publ)

The Board of Directors

Investor Relations                                                       

Melissa Bourestom                                       


00 1 773 387 8504                                                  

Media Contact   

Caren Browning  

King + Company

00 1 212 561 7464

About Dignitana AB (publ)

Dignitana is a Swedish public company based in Lund and manufacturer of the medical cooling device DigniCap®. Dignitana AB is listed on Nasdaq First North Stockholm and has appointed Erik Penser Bank as Certified Adviser. Headquartered in Dallas Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB. For more information visit  and


About Us

Dignitana is a Swedish public company, based in Lund, and manufacturer of the medical cooling device DigniCap®. Dignitana is continuously researching and developing new uses for DigniCap®. Dignitana AB is listed on the OMX Nasdaq First North stock exchange and has appointed Erik Penser Bank as Certified Advisor. For more information visit Dignitana’s core product - DigniCap® - is a patented scalp-cooling system that offers cancer patients the ability to keep their hair during chemotherapy. DigniCap® is developed to provide continuous cooling with high efficacy, safety and acceptable patient comfort.